A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
Clinical trial NCT02033889 · COMPLETED
Trial details
- NCT number
- NCT02033889
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-13
- Primary completion
- 2017-08-03
- Enrollment
- 621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.